Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Vali Health has emerged from stealth with $6 million in funding to develop responsible AI infrastructure for home care agencies, aiming to automate workforce coordination and improve continuity of care.
Lunai Bioworks has secured its first revenue-generating defense contract with the U.S. government through BioSymetrics, formed a national research consortium, and initiated legal proceedings over alleged market manipulation.
LG AI Research has signed a master agreement with D&D Pharmatech to jointly develop oral peptide therapeutics using artificial intelligence, aiming to accelerate drug discovery and improve treatment safety and absorption.
Icarus Medical, based in Charlottesville, Virginia, has closed a $7.2 million Series A funding round to accelerate commercialization and development of its orthopedic bracing technology.
HistoIndex's AI-based quantitative analysis confirmed significant liver fibrosis improvement in D&D Pharmatech's Phase 2 trial of zabopegdutide for MASH, reinforcing earlier histopathological findings.
Coreline Soft and Mint Medical have announced a partnership to integrate Coreline's AVIEW AI imaging platform into Mint Medical's mint Lesion system to support structured lung cancer screening workflows in Germany and beyond.
CCRM and its subsidiary OmniaBio have partnered with Avectas to evaluate an automated cell therapy manufacturing platform aimed at improving scalability and efficiency across a global network of advanced therapy hubs.
DeepIntent has introduced Helix AI, an agentic AI platform designed for healthcare marketers to analyze and activate audiences using natural language across multiple channels.
Toboggan Labs has joined Mila’s Industry Partner Network to strengthen its healthcare AI capabilities, gaining access to research collaboration and knowledge sharing opportunities.
Harbour BioMed and BioMap have formed a strategic partnership to create MegaStream TechBio, an AI based drug development platform focused on complex biologics across multiple therapeutic areas.
IDBS and Alchemi have announced a partnership to connect Alchemi’s AI agents with the IDBS Polar platform, enabling faster and compliant drafting of regulatory filings in the biopharma sector.
cliexa and OpiSafe have announced a partnership to deliver an AI powered platform that combines opioid use disorder risk prediction, tapering management, and behavioral health referral tools for healthcare organizations.
Intelligent Contacts has released Grace, an AI collection agent capable of replacing live agents across the collections process. A top U.S. hospital now processes nearly a quarter of patient payments through Grace, improving speed and satisfaction metrics.
Skin Analytics has received Class III certification for DERM Zero, allowing autonomous skin cancer assessments on standard smartphones. The AI system, already used across NHS hospitals, has detected over 20,000 cancers in the UK.
SkinVision has launched SkinVision Pro, a platform that connects medical practices directly to its AI-powered skin assessment service, enabling doctors to review structured patient data before consultations.
Nivi and MSD announced a collaboration to improve awareness and prevention of HPV-related cervical cancer in India, Indonesia, and Thailand using Nivi’s conversational AI platform.
Florence Healthcare announced at the 2026 DIA Global Annual Meeting that it has enabled Model Context Protocol access across its clinical operations platform, allowing AI agents to interact with workflows at more than 65,000 research sites and 30,000 active protocols.
PulsePoint has launched HCP2DTC Influence, a new capability designed to link healthcare provider intelligence with direct-to-consumer marketing campaigns, enabling dynamic adjustments based on physician engagement and prescribing behavior.
Sensi.AI has introduced its Agentic Operating System, a unified platform that integrates care, operations, and growth for home care agencies. The system uses audio AI and predictive analytics to identify risks, automate tasks, and improve efficiency across caregiving networks.
XtalPi has entered a strategic partnership with an international biopharmaceutical company to develop oral small molecule therapeutics targeting a GPCR receptor, with a potential deal value exceeding $400 million.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
